Hi Corey! Hope U and your family are well.
Cheers, Thierry ________________________________ From: CCP4 bulletin board <CCP4BB@JISCMAIL.AC.UK> on behalf of Corey Strickland <00010491b3cd5784-dmarc-requ...@jiscmail.ac.uk> Sent: Monday, February 24, 2025 9:55 AM To: CCP4BB@JISCMAIL.AC.UK <CCP4BB@JISCMAIL.AC.UK> Subject: [ccp4bb] 2025 Residential School on Medicinal Chemistry and Biology in Drug Discovery You don't often get email from 00010491b3cd5784-dmarc-requ...@jiscmail.ac.uk. Learn why this is important<https://aka.ms/LearnAboutSenderIdentification> EXTERNAL EMAIL– Use caution with any links or file attachments. All, I was asked by the meeting organizers to let the CCP4 community know about the 2025 Residential School on Medicinal Chemistry and Biology in Drug Discovery. See below for information about the course and contact information. It is a great course for those wanting to learn more about how drug discovery works. Sincerely, Corey ------ Drew University’s 38th Annual ResMed Course: The Residential School on Medicinal Chemistry and Biology in Drug Discovery. June 9-13, 2025, In Person or Online ResMed is a week-long graduate/professional-level course providing an accelerated program for medicinal chemists, biologists and other industrial and academic scientists who choose to broaden their knowledge of the drug discovery and development process. The course concentrates on the fundamentals of drug discovery spanning initial target validation through clinical development. The course is taught by distinguished faculty from industry and academia and provides ample opportunity for discussion. Previous attendees with backgrounds in macromolecular crystallography have found the course of great value in their research projects. Topics Covered: Principles of Medicinal Chemistry Cheminformatics Antibody-Drug Conjugates Preclinical Toxicology Drug-like Properties Molecular Modeling Drug Metabolism Kinase Inhibitors In Silico Tools Principals in Assay Development and Interpretation Designing Around Problematic Functionalities AI for Drug Discovery Hit-to-Lead Process Proteolysis-Targeting Chimeras Bioisosteres Case Study Presentations Principles of Lead Optimization Proximity Induced Drug Design Covalent Inhibitors Modern Screening Pharmacokinetics/ Protein Binding Protein-Protein Interactions General Information: Program Information and Registration: Drew University, ResMed www.drew.edu/resmed<http://www.drew.edu/resmed> 36 Madison Ave, Hall of Sciences 319, Madison, NJ 07940 (973) 408-4861 | res...@drew.edu SK Life Science Labs Proprietary / Confidential ________________________________ To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This e-mail message, together with any attachments, contains information of Merck & Co., Inc. (126 East Lincoln Ave., P.O. Box 2000, Rahway, NJ USA 07065) and/or its affiliates, that may be confidential, proprietary copyrighted and/or legally privileged. (Direct contact information for affiliates is available at - Contact us - MSD<https://www.msd.com/contact-us/>.) It is intended solely for the use of the individual or entity named on this message. If you are not the intended recipient, and have received this message in error, please notify us immediately by reply e-mail and then delete it from your system. ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
